Moderna, Inc (MRNA) Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19

Moderna, Inc (NASDAQ: MRNA) FY 2026 Other Release

Newsdesk: